University of Hong Kong, Sinopharm launch trial for Omicron-targeting vaccine | ANC

Coronavirus | Omicron Specific Vaccine Introduced By China's Sinopharm | Trials To Begin SoonПодробнее

Omicron-specific Sinopharm COVID-19 vaccine candidates cleared for clinical trial in Hong kongПодробнее

W.H.O: North Korea COVID outbreak likely 'getting worse' | ANCПодробнее

Sinopharm Debuts New Vaccines Targeting COVID-19 VariantsПодробнее

450 - An Update on COVID-19 Vaccines With Dr. Anna Durbin and Dr. Bill MossПодробнее

Sinovac Vaccine Doesn't Work Against Omicron: StudyПодробнее

China approves clinical trials of Sinopharm's Omicron-specific jabПодробнее

Omicron-specific Sinopharm COVID-19 vaccine candidates cleared for clinical trial in Hong kongПодробнее

J&J, Sinopharm, Sputnik Vaccines Are Weaker Against Omicron: StudyПодробнее

Official says Chinese vaccines at phase 3 trialsПодробнее

Hong Kong begins coronavirus vaccination with China's Sinovac | Covid vaccine update | English NewsПодробнее

Chinese-made Sinopharm vaccines launched in Solomon Islands | The WorldПодробнее

Vaccines and Variants: The State of the COVID-19 Pandemic with Professor Ivan Hung of HKUПодробнее

Hong Kong orders 15 million COVID-19 vaccine shotsПодробнее

Sinovac and Sinopharm Prevent from Hospitalization Related to the Omicron VariantПодробнее

Chinese company uses workers to 'pre-test' vaccineПодробнее

Coronavirus vaccine: Sinopharm ramps up production as China approves jab for use on general publicПодробнее

Three-dose vaccine regimen will be the world's path out of the omicron threat, says Singapore doctorПодробнее

Are Three Doses of Sinovac Effective Against Omicron Deaths? Lessons from Hong-Kong Surge...Подробнее